Immix Biopharma, Inc. (IMMX) Insider Ownership

Historic Ownership Trends

There are no significant Insider Shareholders in Immix Biopharma as of December 12, 2025.

Immix Biopharma, Inc. (IMMX) exhibits a conventional ownership structure with institutions commanding 9.51% of outstanding shares, insider ownership remaining at 43.64%, and other investors holding 46.86%.
Current insider holdings at Immix Biopharma account for 43.64% of total shares outstanding as of December 12, 2025, totaling roughly 12.58Mn shares from the company's 28.83Mn share base.
Over the past 90 days ending December 12, 2025, insider ownership at Immix Biopharma increased by 0.04%, with aggregate insider holdings growing from 12.58Mn to 12.58Mn shares.
As of December 12, 2025, Cfo Gabriel S Morris emerged as Immix Biopharma's top insider buyer over the preceding 90 days, securing 2.60K shares.
Immix Biopharma had no significant insider sales in the last 90 days.

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.

Holder	Position	Shares	Report Date
Ilya M Rachman	CEO And Chairman	1,141,683	10 Dec, 2025
Carey Ng		1,045,221	19 Aug, 2024
Jason Hsu		943,000	26 Dec, 2024
Vladimir P Torchilin	Scientific Co Founder	905,200	20 Dec, 2021
Sean Senn		899,800	22 Jul, 2022
Gabriel S Morris	Cfo	718,273	10 Dec, 2025
Helen C. Adams		174,754	20 May, 2024
Magda Marquet		66,092	20 May, 2024
Jane Buchan		22,455	20 May, 2024

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.

Rows:

Download Data

Transaction Date	Insider Name	Security Class	Transaction Type	Shares Traded	Price	Shares Remaining	Ownership	Code
10 Dec, 2025	Ilya M Rachman	Common Stock	A	746	$6.67	1,141,683	D	P
08 Dec, 2025	Gabriel S Morris	Common Stock	A	156,000	$0.80	426,844	I	X
10 Dec, 2025	Gabriel S Morris	Common Stock	A	770	$6.58	291,429	D	P
17 Sep, 2025	Ilya M Rachman	Common Stock	A	2,500	$2.02	1,140,937	D	P
16 Sep, 2025	Gabriel S Morris	Common Stock	A	2,600	$1.97	290,659	D	P
18 Jun, 2025	Gabriel S Morris	Common Stock	A	2,225	$2.28	288,059	D	P
18 Jun, 2025	Ilya M Rachman	Common Stock	A	2,178	$2.30	1,138,437	D	P
20 Dec, 2024	Jason Hsu			-	-	853,000	D
20 Dec, 2024	Jason Hsu	Common Stock	A	7,700	$2.17	853,000	D	P
23 Dec, 2024	Jason Hsu			-	-	893,000	D
23 Dec, 2024	Jason Hsu	Common Stock	A	40,000	$2.19	893,000	D	P
21 Aug, 2024	Jason Hsu	Common Stock	A	15,000	$2.23	837,200	D	P
22 Aug, 2024	Jason Hsu	Common Stock	A	8,100	$2.25	845,300	D	P
16 Aug, 2024	Carey Ng	Common Stock	A	10,000	$1.86	20,000	D	P
16 Aug, 2024	Carey Ng			-	-	20,000	D
18 Jul, 2024	Jason Hsu	Common Stock	A	3,200	$2.07	816,200	D	P
24 Jul, 2024	Jason Hsu	Common Stock	A	6,000	$2.15	822,200	D	P
07 Jun, 2024	Ilya M Rachman	Common Stock	A	2,600	$2.13	1,136,259	D	P
07 Jun, 2024	Gabriel S Morris	Common Stock	A	2,500	$2.12	285,834	D	P
04 Jun, 2024	Ilya M Rachman	Common Stock	A	3,300	$1.81	1,133,659	D	P

Showing 1 to 20 of 82 transactions

Immix Biopharma, Inc. (IMMX) Insider Ownership

Historic Ownership Trends

Top Direct Holders

Recent Insider Transactions

Create an account

Sign In

Reset Password

Get Pro for 60% off